Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,679 | -24,345 | -291,955 | -227,877 | -150,697 |
| Depreciation Amortization | 3,224 | 1,341 | 2,811 | 1,451 | 551 |
| Accounts receivable | -11,673 | -6,639 | -9,670 | -3,890 | 0 |
| Accounts payable and accrued liabilities | -5,506 | -4,217 | 7,657 | -2,496 | 4,479 |
| Other Working Capital | -6,260 | -8,601 | 7,939 | 6,352 | 11,470 |
| Other Operating Activity | 65,004 | 36,208 | 110,748 | 89,599 | 52,243 |
| Operating Cash Flow | $-23,890 | $-6,253 | $-172,470 | $-136,861 | $-81,954 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -245 | -40 | -431 | -286 | -132 |
| Purchase Of Investment | -38,600 | 0 | -79,729 | -79,728 | -79,513 |
| Sale Of Investment | 0 | 0 | 114,724 | 88,096 | 43,650 |
| Purchase Sale Intangibles | N/A | N/A | -50,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -50,000 | 0 | 1 |
| Investing Cash Flow | $-38,845 | $-40 | $-15,436 | $8,082 | $-35,994 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | N/A | 50,000 | 0 | N/A |
| Common Stock Issued | 6,141 | 3,147 | 26,685 | 14,002 | 4,271 |
| Other Financing Activity | -4,192 | 0 | -1,575 | 0 | 0 |
| Financing Cash Flow | $76,949 | $3,147 | $75,110 | $14,002 | $4,271 |
| Beginning Cash Position | 86,015 | 86,015 | 198,811 | 198,811 | 198,811 |
| End Cash Position | 100,229 | 82,869 | 86,015 | 84,034 | 85,134 |
| Net Cash Flow | $14,214 | $-3,146 | $-112,796 | $-114,777 | $-113,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,890 | -6,253 | -172,470 | -136,861 | -81,954 |
| Capital Expenditure | -245 | -40 | -431 | -286 | -132 |
| Free Cash Flow | -24,135 | -6,293 | -172,901 | -137,147 | -82,086 |